Georg Golor

2.4k total citations · 1 hit paper
52 papers, 1.8k citations indexed

About

Georg Golor is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Hematology. According to data from OpenAlex, Georg Golor has authored 52 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Health, Toxicology and Mutagenesis, 10 papers in Cancer Research and 9 papers in Hematology. Recurrent topics in Georg Golor's work include Toxic Organic Pollutants Impact (11 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Diabetes Treatment and Management (7 papers). Georg Golor is often cited by papers focused on Toxic Organic Pollutants Impact (11 papers), Carcinogens and Genotoxicity Assessment (9 papers) and Diabetes Treatment and Management (7 papers). Georg Golor collaborates with scholars based in Germany, United States and Switzerland. Georg Golor's co-authors include Annika Hanberg, Erkki Yrjänheikki, Mamoun Younes, Christian Schlatter, Fredrik Wærn, A.K.D. Liem, Abraham Brouwer, HJGM Derks, Mark Feeley and G.C. Becking and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and Chemosphere.

In The Last Decade

Georg Golor

52 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Toxic equivalency factors for dioxin-like PCBs

1994 585 citations Georg Golor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Georg Golor Germany	20	715	423	363	286	214	52	1.8k
Andrei Maiseyeu United States	24	754 1.1×	524 1.2×	571 1.6×	129 0.5×	280 1.3×	52	2.4k
H Helge Germany	31	537 0.8×	227 0.5×	365 1.0×	274 1.0×	146 0.7×	104	2.7k
Fumihiro Sata Japan	29	1.2k 1.7×	133 0.3×	407 1.1×	203 0.7×	228 1.1×	99	3.0k
Jinhui Li China	26	352 0.5×	402 1.0×	664 1.8×	562 2.0×	136 0.6×	123	3.1k
Luca De Toni Italy	32	391 0.5×	543 1.3×	631 1.7×	93 0.3×	275 1.3×	121	2.8k
Chunfang Zhu China	25	342 0.5×	395 0.9×	484 1.3×	147 0.5×	123 0.6×	70	1.9k
Noriko Nishimura Japan	30	941 1.3×	162 0.4×	1.2k 3.2×	245 0.9×	116 0.5×	130	3.0k
Hong Cheng China	26	259 0.4×	242 0.6×	735 2.0×	340 1.2×	230 1.1×	137	2.5k
Bo Xu China	30	362 0.5×	173 0.4×	753 2.1×	270 0.9×	363 1.7×	147	3.0k
Tong‐Yuan Tai Taiwan	18	565 0.8×	225 0.5×	449 1.2×	67 0.2×	157 0.7×	24	1.9k

Countries citing papers authored by Georg Golor

Since Specialization

Citations

This map shows the geographic impact of Georg Golor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Golor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Golor more than expected).

Fields of papers citing papers by Georg Golor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Georg Golor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Golor. The network helps show where Georg Golor may publish in the future.

Co-authorship network of co-authors of Georg Golor

This figure shows the co-authorship network connecting the top 25 collaborators of Georg Golor. A scholar is included among the top collaborators of Georg Golor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Georg Golor. Georg Golor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kaufmann, Priska, et al.. (2020). Multiple-dose clinical pharmacology of the selective orexin-1 receptor antagonist ACT-539313. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 108. 110166–110166. 24 indexed citations

Ark, Peter van der, Georg Golor, Luc Van Nueten, Partha Nandy, & Peter de Boer. (2018). Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects. Journal of Psychopharmacology. 32(12). 1330–1340. 16 indexed citations

Dijk, Jan van, et al.. (2018). Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects. European Journal of Drug Metabolism and Pharmacokinetics. 43(6). 685–692. 18 indexed citations

Granhall, Charlotte, Morten Donsmark, Thalia Marie Blicher, et al.. (2018). Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes. Clinical Pharmacokinetics. 58(6). 781–791. 120 indexed citations

Ayalasomayajula, Surya, Parasar Pal, Georg Golor, et al.. (2018). Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects. European Journal of Clinical Pharmacology. 74(9). 1121–1130. 2 indexed citations

Krebs‐Brown, Axel, et al.. (2016). The Hypoxia-inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat (FG-4592) and Warfarin in Healthy Volunteers: A Pharmacokinetic and Pharmacodynamic Drug–Drug Interaction Study. Clinical Therapeutics. 38(4). 918–928. 19 indexed citations

Golor, Georg, et al.. (2013). Antidiuretic Effect of Fedovapagon in Older Males with Benign Prostatic Hyperplasia and Nocturia. Neurourology and Urodynamics. 2 indexed citations

Breitschaft, Astrid, Ke Hu, Karina Hermosillo Reséndiz, Christelle Darstein, & Georg Golor. (2013). Management of hyperglycemia associated with pasireotide (SOM230): Healthy volunteer study. Diabetes Research and Clinical Practice. 103(3). 458–465. 90 indexed citations

Golor, Georg, Debra M. Bensen-Kennedy, Steven M. Haffner, et al.. (2013). Safety and pharmacokinetics of a recombinant fusion protein linking coagulation factor VIIa with albumin in healthy volunteers. Journal of Thrombosis and Haemostasis. 11(11). 1977–1985. 25 indexed citations

10.

Golor, Georg, et al.. (2012). A first-in-man study to evaluate the safety, tolerability, and pharmacokinetics of pasireotide (SOM230), a multireceptor-targeted somatostatin analog, in healthy volunteers. Drug Design Development and Therapy. 6. 71–71. 38 indexed citations

11.

Yin, Ophelia, Neil J. Gallagher, Eren Demirhan, et al.. (2010). Effect of the Proton Pump Inhibitor Esomeprazole on the Oral Absorption and Pharmacokinetics of Nilotinib. The Journal of Clinical Pharmacology. 50(8). 960–967. 67 indexed citations

12.

Schuller, Elisabeth, Bernd Jilma, Georg Golor, et al.. (2008). Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51. Vaccine. 26(34). 4382–4386. 58 indexed citations

13.

Damholt, Birgitte Bentz, Georg Golor, W Wierich, et al.. (2006). An Open‐Label, Parallel Group Study Investigating the Effects of Age and Gender on the Pharmacokinetics of the Once‐Daily Glucagon‐Like Peptide‐1 Analogue Liraglutide. The Journal of Clinical Pharmacology. 46(6). 635–641. 63 indexed citations

14.

Uhl, Wolfgang, Arno Nolting, Georg Golor, Karl Ludwig Rost, & Andreas Kovar. (2006). Safety of Hydroxocobalamin in Healthy Volunteers in a Randomized, Placebo-Controlled Study. Clinical Toxicology. 44(sup1). 17–28. 71 indexed citations

15.

Kovarik, John M., Stefan Hartmann, Christiane Rordorf, et al.. (2002). Effect of Food on Everolimus Absorption: Quantification in Healthy Subjects and a Confirmatory Screening in Patients with Renal Transplants. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 22(2). 154–159. 65 indexed citations

16.

Golor, Georg, Keisuke Yamashita, Wolfgang Körner, Hanspaul Hagenmaier, & Diether Neubert. (2001). Kinetics and inductive potency of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (h7cdd) in rats. Life Sciences. 69(5). 493–508. 5 indexed citations

17.

Körner, Wolfgang, Georg Golor, Thomas F. Schulz, et al.. (2001). Tissue concentrations and induction of a hepatic monooxygenase in male Wistar rats after repeated doses of defined polychlorinated dibenzo-p-dioxin and dibenzofuran (PCDDs and PCDFs) mixtures. Archives of Toxicology. 75(11-12). 653–664. 11 indexed citations

18.

Nagao, Tetsuji, Georg Golor, Hanspaul Hagenmaier, & Diether Neubert. (1993). Teratogenic potency of 2,3,4,7,8-pentachlorodibenzofuran and of three mixtures of polychlorinated dibenzo-p-dioxins and dibenzofurans in mice. Problems with risk assessment using TCDD toxic-equivalency factors. Archives of Toxicology. 67(9). 591–597. 13 indexed citations

19.

Neubert, Reinhard, Ralf Stahlmann, Henk Van Loveren, et al.. (1993). Effects of Small Doses of Dioxins on the Immune System of Marmosets and Rats. Annals of the New York Academy of Sciences. 685(1). 662–686. 28 indexed citations

20.

Hagenmaier, Hanspaul, Thomas Wiesmüller, Georg Golor, et al.. (1990). Transfer of various polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDDs and PCDFs) via placenta and through milk in a marmoset monkey. Archives of Toxicology. 64(8). 601–615. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact